Mark Sims

Corporate Officer/Principal chez CANDEL THERAPEUTICS, INC.

Health Technology

Consumer Services

Profil

Mark Sims is currently Chief Commercial Officer at Candel Therapeutics, Inc. Formerly, Mr. Sims was VP & Global Franchise Head-EGFRm Lung Cancer at AstraZeneca PLC.
Education includes an MBA from Thunderbird School of Global Management and an undergraduate degree from McMaster University.

Postes actifs de Mark Sims

Sociétés	Poste	Début
CANDEL THERAPEUTICS, INC.	Corporate Officer/Principal	06/07/2026

Tous les postes actifs de Mark Sims

Anciens postes connus de Mark Sims

Sociétés	Poste	Fin
ASTRAZENECA PLC	Corporate Officer/Principal	-

Voir l'expérience en détail de Mark Sims

Formation de Mark Sims

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Mark Sims

Sociétés liées

Entreprise privées	4
AstraZeneca PLC AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Thunderbird School of Global Management Thunderbird School of Global Management Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
McMaster University McMaster University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Candel Therapeutics, Inc. Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer	Health Technology